Trade AbbVie ^ABBV

Mint Primer: Why are docs in the dock over a 'work trip'? | Today News

Why AbbVie Inc. (ABBV) Is Among the Best Stocks to Buy and Hold for 3 Years?

First order under Centre's updated UCPMP code, on Abbvie, sees divergent views - The Hindu BusinessLine

Pharma Dept reprimands AbbVie Healthcare for unethical marketing practices | Company News - Business Standard

AbbVie Healthcare India: AbbVie Healthcare under government lens for 'violations', ETPharma

AbbVie (ABBV) Rises Yet Lags Behind Market: Some Facts Worth Knowing - December 24, 2024 - Zacks.com

AbbVie Healthcare under government lens for 'violations' - The Economic Times

AbbVie (ABBV) Benefitted from Top-Line Growth From Its Immunosuppressive Drugs

10 Best Stocks to Buy and Hold For 3 Years

AbbVie (NYSE:ABBV) Shares Up 2% - Time to Buy?

Here’s Why Brown Capital Management Small Company Fund Sold Ironwood Pharmaceuticals (IRWD)

Alembic Pharmaceuticals receives USFDA approval for Divalproex Sodium | Capital Market News - Business Standard

Comparing BriaCell Therapeutics (OTCMKTS:BCTXF) & AbbVie (NYSE:ABBV)

USFDA gives nod to Alembic Pharma’s anti-epileptic drug

Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals - December 20, 2024 - Zacks.com

AbbVie (NYSE:ABBV) Stock Price Down 0.5% on Insider Selling

AbbVie Says Canadian Headache Society Backs Atogepant, OnabotulinumtoxinA | Markets Insider

Is AbbVie Inc. (ABBV) the Safest Dividend Stock to Invest In Now?

Kevin K. Buckbee Sells 1,800 Shares of AbbVie Inc. (NYSE:ABBV) Stock

Novartis, AbbVie Score Win to Block West Virginia Drug Limit Law

AbbVie's SWOT analysis: biopharma giant navigates post-Humira landscape By Investing.com

Abbvie SVP Kevin Buckbee sells stock for $310,032 By Investing.com

AbbVie Inc. (NYSE:ABBV) Receives Average Recommendation of "Moderate Buy" from Brokerages

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know - December 18, 2024 - Zacks.com

Strength Seen in Sanofi (SNY): Can Its 6.7% Jump Turn into More Strength? - December 18, 2024 - Zacks.com

AbbVie's (ABBV) Overweight Rating Reiterated at Piper Sandler Companies

AbbVie (NYSE:ABBV) Price Target Raised to $220.00 at Piper Sandler

AbbVie shares price target lifted, rating held on strong drug outlook By Investing.com

4 Big Drug Stocks That May Continue to Outperform in 2025 - December 17, 2024 - Zacks.com

AbbVie, Novartis Drop Suit Over Kansas Drug Discount Limit Law

AbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors - December 16, 2024 - Zacks.com

ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline - December 16, 2024 - Zacks.com

ABBV's Acquisition Spree Continues: Buy, Sell or Hold the Stock? - December 16, 2024 - Zacks.com

AbbVie (NYSE:ABBV) Shares Up 0.1% – Here’s What Happened

AbbVie (NYSE:ABBV) Stock Price Down 0.1% – Here’s What Happened

Lord Abbett & CO. LLC Decreases Position in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Sold by B. Riley Wealth Advisors Inc.

AbbVie (ABBV) Announces Leadership Transition in Financial Department

Turns Out That Biosimilars Do Impact Biologic Drug Costs | MedPage Today

Asset Advisors Investment Management LLC Has $19.22 Million Position in AbbVie Inc. (NYSE:ABBV)

AbbVie (NYSE:ABBV) Stock Price Up 0.1% - Still a Buy?

AbbVie Inc. (NYSE:ABBV) Stake Lifted by Old North State Trust LLC

Synovus Financial Corp Sells 1,295 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie To Acquire Nimble Therapeutics For $200 Mln In Cash

AbbVie to Acquire Nimble Therapeutics, Further Strengthening

AbbVie Buying Nimble Therapeutics for $200 Million to Boost Immunology Pipeline | Morningstar

Retirement Systems of Alabama Sells 54,280 Shares of AbbVie Inc. (NYSE:ABBV)

24,146 Shares in AbbVie Inc. (NYSE:ABBV) Bought by Oddo BHF Asset Management Sas

AbbVie Inc. (NYSE:ABBV) Shares Sold by Franklin Resources Inc.

AbbVie set to acquire Nimble Therapeutics for $200 million By Investing.com

Stock Yards Bank & Trust Co. Has $14.81 Million Holdings in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Bought by Anchor Investment Management LLC

AbbVie (NYSE:ABBV) Shares Down 0.1% - Should You Sell?

Wilmington Savings Fund Society FSB Boosts Stock Position in AbbVie Inc. (NYSE:ABBV)

Arvest Bank Trust Division Takes Position in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Sold by World Investment Advisors LLC

Sanctuary Advisors LLC Has $104.43 Million Stake in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Bought by Pine Valley Investments Ltd Liability Co

Wealthquest Corp Has $545,000 Stock Holdings in AbbVie Inc. (NYSE:ABBV)

Why AbbVie Inc. (ABBV) Is the Best Safe Stock to Buy According to Analysts?

AbbVie Inc. (NYSE:ABBV) Shares Purchased by Hohimer Wealth Management LLC

AbbVie's SWOT analysis: stock resilience amid humira decline fuels growth By Investing.com

RA Capital Management Announces Close of $1.4 Billion Acquisition of Aliada Therapeutics by AbbVie | Morningstar

AbbVie (NYSE:ABBV) Shares Down 0.1% - Here's What Happened

Wall Street analysts love these dividend aristocrats heading into new year

Rehmann Capital Advisory Group Sells 380 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Sold by McIlrath & Eck LLC

Soltis Investment Advisors LLC Sells 765 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Stock Position Trimmed by McIlrath & Eck LLC

AbbVie Inc. (NYSE:ABBV) Shares Purchased by Executive Wealth Management LLC

Invst LLC Has $770,000 Stock Holdings in AbbVie Inc. (NYSE:ABBV)

HEALTHCARE: AbbVie (ABBV: A3 pos / A-): Aliada Acquisition

Medical Aesthetics Market worth $35.32 billion by 2030

Arete Wealth Advisors LLC Makes New Investment in AbbVie Inc. (NYSE:ABBV)

Toronto Dominion Bank Reduces Stake in AbbVie Inc. (NYSE:ABBV)

Chiron Investment Management LLC Buys Shares of 10,752 AbbVie Inc. (NYSE:ABBV)

Groupama Asset Managment Purchases 38,974 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie acquires Aliada to enhance Alzheimer's treatment By Investing.com

AbbVie Completes Acquisition Of Aliada

Hope for Parkinson’s disease symptoms is found in late-stage drug study

AbbVie (NYSE:ABBV) Trading Down 1.4% - Here's What Happened

AbbVie Inc. (NYSE:ABBV) Shares Sold by Geode Capital Management LLC

AbbVie Inc. (NYSE:ABBV) Stock Holdings Lifted by Ashford Capital Management Inc.

Medincell Publishes Its Consolidated Half-year Financial Results | Morningstar

AbbVie (NYSE:ABBV) Given “Neutral” Rating at Bank of America

Greenwood Gearhart Inc. Buys New Holdings in AbbVie Inc. (NYSE:ABBV)

TD Cowen names AbbVie a top pick for 2025 with buy stock rating By Investing.com

AbbVie's (ABBV) Neutral Rating Reiterated at Bank of America

Geode Capital Management LLC Lowers Stake in AbbVie Inc. (NYSE:ABBV)

Goodman Advisory Group LLC Purchases 1,620 Shares of AbbVie Inc. (NYSE:ABBV)

The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group

SPOT stock price: Spotify stock reaches all-time highs

DRCT stock price today: Direct Digital Holdings spikes on high-volume move

Stock Market Today: Dow Jones Closes Higher for Third Consecutive Day

Morning Note: GDP in the UK, Spain and Canada to Shake Markets Today

Bitcoin ETFs Experience Record Outflows Amid Crypto Market Decline

Analyst revises Amazon stock forecast following major 'moonshot' initiative

Stock market today: 3 bullish stocks that J.P. Morgan Just Upgraded

Bitcoin news today: Jerome Powell Says Fed Won’t Hold Bitcoin